Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

June 2014

Stryker to Acquire Small Bone Innovations for up to $375M BY ANDREW VAHRADIAN, JUNE 30, 2014

Stryker entered a definitive agreement to acquire Small Bone Innovations (SBi) in an all cash, asset purchase transaction for up to $375 million, or 7.8x LTM revenues. SBi manufactures orthopedic devices and instruments for upper and lower extremity small bone... more

Musculoskeletal News Roundup 27-June-14 BY ANDREW VAHRADIAN, JUNE 27, 2014

Riverside Company to acquire Global Orthopaedic Technologies...Ellipse Technologies, Titan Spine receive various approvals...Arthrosurface, DePuy, NuVasive, Pluristem, Titan Spine product updates...BONESUPPORT, Bone Therapeutics, Cellular Biomedicine, DFINE, Orthocell, Paradigm Spine, Spinal Kinetics clinical updates...Olympus Biotech to close plant...Ortho Kinematics, Medacta open new facilities...Tissue Regeneration Systems enters agreement with Johnson & Johnson to develop implant line...Amedica, Halifax Biomedical distribution updates more

Dental News Roundup June 2014 BY MATTHEW JAFFE, JUNE 26, 2014

Financial results from Align Technology, Nobel Biocare, Patterson Companies, Sirona, Straumann, and Henry Schein... Henry Schein M&A... Legal update from Align Technology... Straumann distribution agreements... Appointments at Henry Schein, Patterson Companies more

Johnson & Johnson Plans to Develop a Line of 3-D Printed Reconstructive Implants BY ANDREW VAHRADIAN, JUNE 26, 2014

Last month, Johnson & Johnson (JNJ) announced that the company plans to file for more than 30 major product approvals within its Medical Device & Diagnostic (MD&D) unit by the end of 2016, in order to bolster the segment's overall... more

Musculoskeletal News Roundup 18-June-14 BY MATTHEW JAFFE, JUNE 18, 2014

Medtronic to acquire Covidien for $49.2 billion... Benvenue Medical funding... Regulatory news from OrthAlign, Expanding Orthopedics... Product updates from Acumed, Wright Medical, Aastrom Biosciences... SpinalCyte animal trials more

Medtronic to Acquire Covidien for $42.9B BY MATTHEW JAFFE, JUNE 16, 2014

Medtronic announced that they have entered a definitive agreement to acquire Covidien in a total cash and stock transaction of $42.9 billion. Under the terms of the transaction, for each share held, a Covidien shareholder will receive $35.19 in cash... more

Researchers Utilize Laser Therapy to Regenerate Tooth Dentin BY ANDREW VAHRADIAN, JUNE 16, 2014

A new study conducted by a team of researchers from Harvard University and published in Science Translational Medicine, demonstrated that lasers are able to regenerate parts of damaged teeth and in the future, be used to prevent root canal treatments.... more

Musculoskeletal News Roundup 13-June-14 BY MATTHEW JAFFE, JUNE 13, 2014

Materialise IPO... European Commission suspends Zimmer/Biomet review...First customized 3-D printed spinal cage implanted... FDA approvals for Choice Spine, Materialise... Product Introduction and Updates for Bioventus, Medicrea, Symmetry Medical, SpineGuard, ulrich Medical, VEXIM... Legal news from Medtronic... Microport expansion... Integra LifeSciences distribution more

Materialise Files IPO BY MATTHEW JAFFE, JUNE 13, 2014

Materialise NV, a Belgian company, filed an IPO to raise $104 million in 8 million American Depository Shares (ADS) at a price range of $12 to $14 per share. The company plans to use the proceeds to expand their 3-D... more

Microport to Expand Wright Medical Presence BY JOHN MCCORMICK, JUNE 13, 2014

This week, MicroPort, China's largest and most successful private medtech company, announced that it will be investing $100 million over the next 5 years to add to Wright Medical's training capabilities. Having recently closed its acquisition of the Wright Medical... more

Study Links Rise in Total Knee and Hip Replacement Volumes to Obesity, Especially In Younger Adults BY ANDREW VAHRADIAN, JUNE 11, 2014

According to a recent study published in the Journal of Bone and Joint Surgery (JBJS), an increase in the prevalence of overweight and obesity levels in the U.S. accounted for 95% of the higher demand for knee replacements, with younger... more

Humana Sues Medtronic Over Marketing Strategy of INFUSE BY ANDREW VAHRADIAN, JUNE 9, 2014

Last week, Humana filed a lawsuit against Medtronic accusing the defendant of falsely representing its INFUSE Bone Graft product as "safe and effective" in spinal fusion surgeries. INFUSE is Medtronic's proprietary formulation of recombinant human bone morphogenetic protein-2 (rhBMP-2), which... more

Musculoskeletal News Roundup 6-Jun-14 BY ANDREW VAHRADIAN, JUNE 6, 2014

Aurora Spine, K2M report financial results...Orthocell IPO, Premia Spine financing...Aastrom Biosciences acquires Sanofi CTRM division...Medtronic reported to be bidding for Smith & Nephew...Kinamed, SafeWire, Tyber Medical receive product approvals...Arthrosurface announces first procedures...Rotation Medical's new rotator cuff technique...aap Implantate new patent...ConforMIS, DFINE, Misonix Seikagaku announce clinical results...Zyga announces enrollment more

Spinal Kinetics Completes $34M Financing and Settles IP Litigation with Johnson & Johnson BY ANDREW VAHRADIAN, JUNE 5, 2014

Spinal Kinetics completed a $34 million private financing and entered a global settlement of all patent litigation with Synthes and Depuy Synthes (Johnson & Johnson) with respect its M6 Cervical and Lumbar artificial disc implants. The company's M6-C artificial cervical... more

Medtronic Reported to be Considering an Acquisition of Smith & Nephew BY ANDREW VAHRADIAN, JUNE 5, 2014

Medtronic is reported to be considering an acquisition of Smith & Nephew. Presently, no offer is imminent as Medtronic's bid preparations are believed to be at an early stage. The transaction would impart greater leverage to Medtronic with payor and... more

Orthocell Limited Announces IPO BY ANDREW VAHRADIAN, JUNE 2, 2014

Orthocell Limited announced its intention to list on the Australian Securities Exchange (ASX) by launching an initial public offering (IPO) process, proposing to raise $8 million by offering 20 million shares at an offer price of $0.40 a share. Orthocell... more

Aastrom Biosciences Completes Acquisition of Sanofi's Cell Therapy & Regenerative Medicine Division BY ANDREW VAHRADIAN, JUNE 2, 2014

Aastrom Biosciences completed its acquisition of Sanofi's cell therapy & regenerative medicine (CTRM) business unit (currently operating under Genzyme A/S) for a purchase price of $6.5 million or 0.1x LTM revenues. The transaction expands Aastrom's cell therapy portfolio and provides... more

Complete Archive